Before Thursday’s session, JPMorgan cut the stock to “underweight”, stating that it had risen “far above the level we feel can be justified by even the most optimistic view of underlying earnings fundamentals.”
Before Thursday’s session, JPMorgan cut the stock to “underweight”, stating that it had risen “far above the level we feel can be justified by even the most optimistic view of underlying earnings fundamentals.”